Definitive Healthcare Corp.

DH

US24477E1038

Software

Market Closed - Nasdaq Other stock markets 04:30:01 2024-05-06 pm EDT			5-day change	1st Jan Change
7.34 ^USD	+4.41%		+2.66%	-26.16%

Apr. 16	Definitive Healthcare Introduces Carevoyance Sales Enablement Solution for Medtech Industry	CI
Mar. 22	Definitive Healthcare Collaborating With VML Health on Key Opinion Leader Management Tool for Clients	MT

Definitive Healthcare Corp.(NasdaqGS:DH) added to S&P TMI Index

December 20, 2021 at 12:00 am EST

Latest news about Definitive Healthcare Corp.

Definitive Healthcare Introduces Carevoyance Sales Enablement Solution for Medtech Industry	Apr. 16	CI
Definitive Healthcare Collaborating With VML Health on Key Opinion Leader Management Tool for Clients	Mar. 22	MT
Definitive Healthcare and VML Health Announce Partnership to Transform Key Opinion Leader Management	Mar. 22	CI
Deutsche Bank Adjusts Definitive Healthcare Price Target to $10 From $9, Maintains Hold Rating	Mar. 01	MT
Barclays Adjusts Price Target on Definitive Healthcare to $11 From $10, Maintains Equalweight Rating	Mar. 01	MT
Definitive Healthcare Seeks Inorganic Growth	Feb. 28	CI
Transcript : Definitive Healthcare Corp., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Earnings Flash (DH) DEFINITIVE HEALTHCARE Reports Q4 EPS $0.07, vs. Street Est of $0.08	Feb. 28	MT
Earnings Flash (DH) DEFINITIVE HEALTHCARE Posts Q4 Revenue $65.9M, vs. Street Est of $66M	Feb. 28	MT
Definitive Healthcare Corp. Provides Earnings Guidance for the First Quarter	Feb. 28	CI
Definitive Healthcare Corp. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 28	CI
Definitive Healthcare Corp. (NasdaqGS:DH) acquired Carevoyance business line of H1 Insights, Inc for $14 million.	Feb. 27	CI
North American Morning Briefing : TSMC Results -2-	Jan. 18	DJ
Definitive Healthcare Shares Drop After Downgrade From Needham	Jan. 17	MT
Stifel Adjusts Definitive Healthcare's Price Target to $11 From $12, Keeps Buy Rating	Jan. 17	MT
Needham Downgrades Definitive Healthcare to Hold From Buy	Jan. 17	MT
Definitive Healthcare Says Musslewhite Steps Down as CEO; Founder Krantz Named in Interim; 2024 Guidance Set	Jan. 16	MT
Definitive Healthcare Corp. Announces Resignation of Robert Musslewhite as Member of the Board of Directors	Jan. 16	CI
Definitive Healthcare Corp. Announces Chief Executive Officer Changes	Jan. 16	CI
Definitive Healthcare Corp. Reaffirms Earnings Guidance for the Fourth Quarter 2023 and Provides Earnings Guidance for the Full Year 2024	Jan. 16	CI
North American Morning Briefing : Boeing Drags -2-	Jan. 08	DJ
Canaccord Genuity Downgrades Definitive Healthcare to Hold From Buy, Price Target is $10	Jan. 05	MT
Definitive Healthcare Plans to Cut Workforce by 154 People	Jan. 04	MT
Barclays Raises Definitive Healthcare Price Target to $10 From $7, Maintains Equal Weight Rating	Dec. 27	MT
Deutsche Bank Cuts Definitive Healthcare Price Target to $9 From $14, Maintains Hold rating	Nov. 06	MT

Chart Definitive Healthcare Corp.

Duration

Period

More charts

Definitive Healthcare Corp. is engaged in transforming data, analytics, and expertise into healthcare commercial intelligence. The Companyâs solutions are designed to provide information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. Its software-as-a-service (SaaS) platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. It transforms data into intelligence through artificial intelligence (AI) and machine learning (ML) algorithms that ingest, cleanse, link, and analyze the data to create new intelligence and analytics. All of its business is conducted through AIDH TopCo, LLC (Definitive OpCo).

Sector

Software

Calendar

04:05pm - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Definitive Healthcare Corp.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

7.34 USD

Average target price

10.4 USD

Spread / Average Target

+41.69%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Software

	1st Jan change	Capi.
DEFINITIVE HEALTHCARE CORP.	-26.16%	828M
MICROSOFT CORPORATION	+9.97%	3,022B
SYNOPSYS INC.	+5.95%	81.91B
CADENCE DESIGN SYSTEMS, INC.	+4.71%	76.64B
DASSAULT SYSTÈMES SE	-16.04%	52.31B
PALANTIR TECHNOLOGIES INC.	+46.83%	51.96B
ATLASSIAN CORPORATION	-23.58%	47.77B
THE TRADE DESK, INC.	+26.96%	43.3B
SEA LIMITED	+63.28%	38.29B
ROBLOX CORPORATION	-12.27%	25.1B

Other Software